Nosocomial Infections: Causes, Types, and Prevention

Nosocomial infections, more commonly called hospital-acquired infections, are infections that patients develop during or shortly after receiving care in a healthcare facility and that were not present or incubating at the time of admission. They rank among the most frequent complications of hospital care worldwide, increasing both the risk of death and the length of time patients spend in the hospital. Despite decades of progress in infection control, these infections remain stubbornly common, driven by a combination of invasive devices, antibiotic-resistant organisms, and the sheer density of vulnerable people sharing enclosed spaces.

The Four Main Types

Most hospital-acquired infections fall into a few broad categories tied to specific devices or procedures. Catheter-associated urinary tract infections are the most common type globally. They occur when bacteria colonize an indwelling urinary catheter, forming a sticky layer called a biofilm on the catheter’s surface. That biofilm protects the bacteria from both the immune system and antibiotics, making these infections difficult to clear as long as the catheter remains in place.1PubMed Central. Role of biofilm in catheter-associated urinary tract infection

Central line-associated bloodstream infections develop when bacteria enter the bloodstream through an intravenous catheter placed in a large vein. The risk depends on a range of factors including where the catheter is inserted on the body, the technique used during insertion, and how well the catheter is maintained afterward.2PubMed Central. Prevention of Central Line-Associated Bloodstream Infections Because bacteria gain direct access to the bloodstream, these infections can become life-threatening quickly.

Surgical site infections occur when bacteria contaminate an incision during or after surgery. The organisms most frequently responsible include Staphylococcus aureus (including drug-resistant strains), Pseudomonas aeruginosa, E. coli, and several other common hospital bacteria.3Journal of Trauma and Injury. Surgical site infections: a comprehensive review Risk factors span three categories: patient-related (age, diabetes, obesity, malnutrition, smoking), procedure-related (longer surgeries, open rather than minimally invasive approaches, use of drains), and environmental (contaminated instruments, inadequate operating room ventilation, too much foot traffic in the OR). A study at one teaching hospital in Ethiopia found that operations lasting two hours or more roughly doubled the odds of a surgical site infection, and malnourished patients faced more than four times the risk.4IJID Regions. Bacterial surgical site infections: prevalence, antimicrobial susceptibility patterns, and associated risk factors among patients at Bule Hora University Teaching Hospital, Southern Ethiopia

Ventilator-associated pneumonia develops in patients on mechanical breathing machines, typically in intensive care units. Microaspiration of stomach contents past the breathing tube is a key trigger. A prospective study of ICU patients found that those ventilated with the lowest positive airway pressure settings had microaspiration rates above 50%, while higher pressure settings cut that rate roughly in half and shortened the time patients spent on the ventilator.5PubMed Central. Effect of positive end-expiratory pressure on risk of microaspiration and ventilator-associated pneumonia in mechanically ventilated ICU patients: a prospective study

How These Infections Spread

The hands of healthcare workers are the single most important vehicle for transmitting pathogens between patients. Doctors, nurses, and other staff touch patients, equipment, and room surfaces dozens of times per shift, and bacteria hitch a ride from one contact point to the next. A study of outpatient care settings found significant contamination on workers’ hands at critical moments of patient contact, confirming that the transmission risk extends well beyond inpatient wards.6PubMed. Health care worker hand contamination at critical moments in outpatient care settings

Hospital surfaces play a supporting role. Bedrails, call buttons, bedside table handles, light switches, and door handles are all high-touch surfaces that accumulate both common and drug-resistant bacteria, viruses, and fungi. Improved cleaning and disinfection of these surfaces has been shown to decrease infection rates.7PubMed Central. High-touch surfaces: microbial neighbours at hand The problem is that standard cleaning does not always eliminate the most dangerous organisms. One hospital study recovered methicillin-resistant, multidrug-resistant Staphylococcus aureus from a bedside table handle both before and after routine cleaning. The strain was a strong biofilm producer, meaning it could anchor itself to the surface and resist standard wiping protocols.8PubMed Central. Persistence of Biofilm-Forming and Multidrug-Resistant Staphylococcus aureus on High-Touch Hospital Surfaces Despite Routine Cleaning and Disinfection

How Long Pathogens Survive on Surfaces

One reason environmental contamination is so hard to control is the remarkable staying power of hospital pathogens on dry, inanimate surfaces. A scoping review of the published literature found that common organisms of concern to infection control can persist on surfaces for months. The longest-surviving organism reported was Klebsiella pneumoniae, which was found to have persisted for 600 days on an inanimate surface.9PubMed. How long do nosocomial pathogens persist on inanimate surfaces? A scoping review That kind of durability means a room that housed an infected patient weeks or even months ago can still harbor enough organisms to infect the next occupant if disinfection was incomplete.

The Clostridioides difficile Problem

Among hospital-acquired infections, C. difficile stands out because the healthcare system itself creates the conditions for it. C. difficile spores are naturally present in the environment, but a healthy gut microbiome keeps them in check. Antibiotics disrupt that protective ecosystem, killing off beneficial gut bacteria and creating a vacant niche where C. difficile can germinate, multiply, and produce the toxins that cause severe colitis.10Gastroenterology. Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile The irony is sharp: a patient admitted for one problem may receive antibiotics that solve that problem while simultaneously setting up a dangerous new infection.

Research in animal models has confirmed that different antibiotics produce different patterns of gut disruption, and that the specific changes to the microbial community determine whether C. difficile can gain a foothold.11PubMed Central. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile This has important practical implications: not all antibiotics carry the same C. difficile risk, and hospitals that carefully manage which antibiotics they prescribe can reduce their rates of this infection substantially.

Drug-Resistant Organisms in Hospitals

Hospital-acquired infections are disproportionately caused by drug-resistant bacteria, partly because hospitals concentrate the most vulnerable patients and the heaviest antibiotic use in one place. A systematic review and meta-analysis of hospital-acquired infections in low- and lower-middle-income countries found that organisms like Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae show alarming rates of carbapenem resistance, especially in ICUs where these bacteria are the leading causes of invasive infections.12PubMed Central. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis Carbapenems are often considered last-resort antibiotics, so resistance to them leaves very few treatment options. Rising carbapenem use in these settings is accelerating the problem.

The Human and Financial Cost

Hospital-acquired infections are not just a medical inconvenience. A prospective cohort study found that patients who developed an infection during their hospital stay had nearly double the mortality rate compared to matched patients who did not, and they stayed in the hospital an average of eight days longer.13PubMed Central. Clinical and economic burden of healthcare-associated infections: A prospective cohort study Financially, a case-control study found that the median hospital cost for infected patients was roughly twice that of uninfected patients, with medication costs being the largest driver of the gap.14PubMed Central. The Extra Length of Stay, Costs, and Mortality Associated With Healthcare‐Associated Infections: A Case‐Control Study

These costs multiply across a health system. And because many of these infections are preventable, every dollar spent treating one represents both a clinical failure and an economic waste.

Hand Hygiene Remains the Single Best Defense

The evidence on hand hygiene is about as strong as it gets in infection prevention. A landmark hospital-wide campaign that promoted alcohol-based hand disinfection at the bedside tracked results over five years. Overall hand hygiene compliance improved markedly, and during the same period, nosocomial infection prevalence dropped from about 17% to 10%. MRSA transmission rates fell by more than half.15The Lancet. Effectiveness of a hospital-wide programme to improve hand hygiene compliance A more recent long-term intervention study showed an even tighter relationship: as hand hygiene compliance rose over a six-year period, the hospital infection rate fell from 2.63% to 0.90%, with a strong statistical correlation between the two trends.16PubMed Central. Enhancing hand hygiene compliance in healthcare settings: a long time intervention study

Sustaining high compliance remains a challenge. Automated monitoring systems can track hand hygiene events far more comprehensively than human observers. One hospital’s electronic system captured over 632,000 hand hygiene events during the study period, compared to just 480 events recorded by human observers, and helped the hospital maintain compliance above 95%.17PubMed. An automated hand hygiene compliance system is associated with improved monitoring of hand hygiene The technology’s main benefit may be in making compliance visible and sustained rather than producing dramatic infection drops on its own.

UV Disinfection and Room Decontamination

Ultraviolet light devices and hydrogen peroxide vapor systems represent a newer layer of defense, used to decontaminate patient rooms after discharge. Multiple studies have shown these technologies can inactivate drug-resistant pathogens on hospital surfaces and reduce colonization or infection in patients subsequently admitted to those rooms.18PubMed Central. Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials

The picture is more nuanced than the headlines sometimes suggest, though. A systematic review and meta-analysis of UV-C disinfection systems found no statistically significant reduction in C. difficile or vancomycin-resistant Enterococcus infection rates, though there was a modest reduction in infections caused by certain gram-negative bacteria.19PubMed Central. Effectiveness of ultraviolet-C disinfection systems for reduction of multi-drug resistant organism infections in healthcare settings: A systematic review and meta-analysis Another systematic review found more variability: some studies reported up to a 70% decrease in C. difficile rates in high-risk areas like ICUs, but other settings saw no significant improvement. UV disinfection appears most effective as an add-on to standard cleaning rather than a replacement for it.20PubMed. Impact of ultraviolet light disinfection on reducing hospital-associated infections: a systematic review in healthcare environments

Antibiotic Stewardship

Because antibiotic use drives both drug resistance and C. difficile infections, programs designed to optimize prescribing have become a cornerstone of infection prevention. A large systematic review and meta-analysis found that antibiotic stewardship programs reduced infections and colonization with multidrug-resistant gram-negative bacteria by about half, MRSA infections by roughly a third, and C. difficile infections by about a third as well.21The Lancet Infectious Diseases. Effect of antibiotic stewardship programmes on the incidence of infections and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis

The mechanism for C. difficile reduction is particularly clear. When hospitals restrict high-risk antibiotics (the ones most likely to disrupt protective gut bacteria), C. difficile cases drop. One hospital study documented a significant and sustained decline in C. difficile incidence after restricting its highest-risk antibiotics, with no prior downward trend before the intervention.22Journal of Antimicrobial Chemotherapy. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection A separate study at another hospital confirmed the same pattern, finding that the reduction in high-risk antibiotic use was directly associated with a declining trend in C. difficile rates.23Journal of Antimicrobial Chemotherapy. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings

Do Financial Penalties Actually Reduce Infections?

Starting in 2008, Medicare in the United States stopped paying hospitals for certain preventable infections, and later added a Hospital-Acquired Condition Reduction Program that penalizes the worst-performing hospitals. The results have been mixed. An analysis of the penalty program found that 98% of hospitals in the worst-performing quartile in 2013 had reduced their infection scores by 2020, compared to only about 39% of hospitals in the better-performing quartiles.24PubMed Central. Evaluating the Effect of Financial Penalty on Hospital-Acquired Infections That suggests the penalties motivated the worst performers to improve.

But a separate study examining the earlier 2008 nonpayment policy found no measurable effect on rates of catheter-associated bloodstream infections, catheter-associated urinary tract infections, or ventilator-associated pneumonia. Infection rates had already been declining before the policy took effect, and the policy did not accelerate that trend.25PubMed. Effect of nonpayment for preventable infections in U.S. hospitals State-level mandatory reporting laws, by contrast, were associated with significantly lower bloodstream infection rates in ICUs, with declines appearing even before the laws took formal effect, likely because hospitals started preparing in advance.26PubMed Central. Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units Transparency, it seems, may be at least as powerful a motivator as financial punishment.

The Problem Does Not End at Discharge

Hospital-acquired infections do not always resolve when a patient goes home. An analysis of over 700,000 hospitalizations involving a diagnosed hospital-acquired infection found that about 2.5% resulted in a readmission for the same type of infection. C. difficile infections had the highest bounce-back rate, with 4% of patients returning for the same diagnosis. Interestingly, patients discharged to skilled nursing facilities had a lower rate of linked readmissions than those sent home, possibly because nursing facilities provide ongoing clinical monitoring that catches and manages relapses.27PubMed Central. The Role of Post-Acute Care in Readmissions for Preexisting Healthcare-Associated Infections

Nursing homes themselves are also a front line for prevention. A large trial tested a decolonization protocol for nursing home residents, using nasal antiseptic ointment and antiseptic body wash to reduce the bacterial load on residents’ skin and in their noses. The intervention cut infection-related hospital transfers by about 17% compared to routine care, with a number needed to treat of roughly 10 to prevent one infection-related hospitalization.28PubMed Central. Decolonization in Nursing Homes to Prevent Infection and Hospitalization That is a meaningful effect from a relatively simple intervention, and it highlights how much of the infection prevention challenge extends beyond hospital walls.

Genomic Surveillance Is Changing Outbreak Response

One of the more promising developments in infection control is the use of whole-genome sequencing to track outbreaks in real time. Traditional methods for investigating an outbreak rely on culture results, patient timelines, and staff interviews to piece together who transmitted what to whom. Genomic sequencing can answer that question far more precisely. In one well-documented outbreak of carbapenem-resistant Klebsiella pneumoniae, sequencing revealed that three separate transmission chains originated from a single patient who had been discharged three weeks before the next case appeared. Standard epidemiological investigation would not have identified that patient as the source.29PubMed Central. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing

More recently, genomic tools have been used to track the spread of resistance genes themselves, not just the bacteria carrying them. An investigation of an outbreak involving NDM-5-producing bacteria (a type that carries a gene for broad antibiotic resistance on a mobile piece of DNA) used prospective genomic methods alongside traditional infection control to identify and contain the spread.30PubMed Central. Real-time genomic epidemiologic investigation of a multispecies plasmid-associated hospital outbreak of NDM-5-producing Enterobacterales infections Newer software platforms are pushing the turnaround time for this kind of analysis down from days to minutes, which could eventually make genomic tracking a routine part of infection control rather than a research tool deployed after the fact.31PubMed. The need for speed: ultra-rapid high-resolution outbreak analysis in a front-line hospital microbiology laboratory

The Psychological Toll of Isolation

When a patient develops a hospital-acquired infection with a drug-resistant or highly transmissible organism, they are typically placed in contact or droplet isolation: a private room, gowning and gloving required for anyone entering, restricted visitors. The medical rationale is sound, but the psychological cost is real. A systematic review found that the majority of studies on isolated patients showed higher scores for depression, anxiety, anger, fear, and loneliness compared to non-isolated patients.32PubMed Central. Adverse effects of isolation in hospitalised patients: a systematic review A later systematic review with meta-analysis put numbers to the effect, finding that isolated patients had pooled depression scores about 1.3 standard deviations higher and anxiety scores about 1.5 standard deviations higher than non-isolated patients, though with considerable variation across studies.33PubMed. Impact of isolation on hospitalised patients who are infectious: systematic review with meta-analysis

Staff may also visit isolated patients less frequently, and for shorter periods, because of the time required to gown up. The practical result is that patients dealing with a hospital-acquired infection often receive less social contact and less attentive care precisely when they are sickest, creating a compounding cycle of medical and emotional harm that rarely gets discussed alongside infection rates and cost figures.

Ryan Dawson

Infectious disease specialist Ryan Dawson holds ABIM certification in internal medicine and infectious disease and has 15 years of practice on a hospital consult service. He earned his MD at Yale University. His clinical work includes cellulitis, abscesses, MRSA, fungal skin and nail infections and diabetic foot infections, and he serves on an antimicrobial stewardship team. He writes about skin and soft-tissue infections, antibiotic resistance and how the immune system fights infection.